INNOVIVA INC (INVA) Fundamental Analysis & Valuation

NASDAQ:INVA • US45781M1018

Current stock price

23.415 USD
-0.09 (-0.36%)
Last:

This INVA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. INVA Profitability Analysis

1.1 Basic Checks

  • In the past year INVA was profitable.
  • In the past year INVA had a positive cash flow from operations.
  • In the past 5 years INVA has always been profitable.
  • Each year in the past 5 years INVA had a positive operating cash flow.
INVA Yearly Net Income VS EBIT VS OCF VS FCFINVA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

  • INVA has a better Return On Assets (16.58%) than 95.29% of its industry peers.
  • The Return On Equity of INVA (23.12%) is better than 92.67% of its industry peers.
  • With an excellent Return On Invested Capital value of 7.51%, INVA belongs to the best of the industry, outperforming 85.34% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for INVA is below the industry average of 13.11%.
Industry RankSector Rank
ROA 16.58%
ROE 23.12%
ROIC 7.51%
ROA(3y)10.94%
ROA(5y)15.78%
ROE(3y)17.71%
ROE(5y)31.01%
ROIC(3y)8.6%
ROIC(5y)13.83%
INVA Yearly ROA, ROE, ROICINVA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 200

1.3 Margins

  • INVA's Profit Margin of 65.92% is amongst the best of the industry. INVA outperforms 97.91% of its industry peers.
  • In the last couple of years the Profit Margin of INVA has remained more or less at the same level.
  • With an excellent Operating Margin value of 39.81%, INVA belongs to the best of the industry, outperforming 97.91% of the companies in the same industry.
  • In the last couple of years the Operating Margin of INVA has declined.
  • INVA has a better Gross Margin (74.80%) than 81.68% of its industry peers.
  • INVA's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 39.81%
PM (TTM) 65.92%
GM 74.8%
OM growth 3Y-13.95%
OM growth 5Y-16.03%
PM growth 3Y0.7%
PM growth 5Y-0.21%
GM growth 3Y-7.93%
GM growth 5YN/A
INVA Yearly Profit, Operating, Gross MarginsINVA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50 100 150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. INVA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), INVA is destroying value.
  • Compared to 1 year ago, INVA has more shares outstanding
  • INVA has less shares outstanding than it did 5 years ago.
  • INVA has a better debt/assets ratio than last year.
INVA Yearly Shares OutstandingINVA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
INVA Yearly Total Debt VS Total AssetsINVA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 3.57 indicates that INVA is not in any danger for bankruptcy at the moment.
  • INVA has a Altman-Z score of 3.57. This is in the better half of the industry: INVA outperforms 66.49% of its industry peers.
  • INVA has a debt to FCF ratio of 1.38. This is a very positive value and a sign of high solvency as it would only need 1.38 years to pay back of all of its debts.
  • With an excellent Debt to FCF ratio value of 1.38, INVA belongs to the best of the industry, outperforming 94.76% of the companies in the same industry.
  • A Debt/Equity ratio of 0.22 indicates that INVA is not too dependend on debt financing.
  • With a Debt to Equity ratio value of 0.22, INVA perfoms like the industry average, outperforming 40.31% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 1.38
Altman-Z 3.57
ROIC/WACC0.85
WACC8.89%
INVA Yearly LT Debt VS Equity VS FCFINVA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

2.3 Liquidity

  • A Current Ratio of 14.64 indicates that INVA has no problem at all paying its short term obligations.
  • INVA's Current ratio of 14.64 is amongst the best of the industry. INVA outperforms 87.96% of its industry peers.
  • INVA has a Quick Ratio of 13.85. This indicates that INVA is financially healthy and has no problem in meeting its short term obligations.
  • INVA has a better Quick ratio (13.85) than 85.86% of its industry peers.
Industry RankSector Rank
Current Ratio 14.64
Quick Ratio 13.85
INVA Yearly Current Assets VS Current LiabilitesINVA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. INVA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 1505.26% over the past year.
  • Measured over the past years, INVA shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.59% on average per year.
  • The Revenue has grown by 14.67% in the past year. This is quite good.
  • Measured over the past years, INVA shows a small growth in Revenue. The Revenue has been growing by 4.08% on average per year.
EPS 1Y (TTM)1505.26%
EPS 3Y11.17%
EPS 5Y8.59%
EPS Q2Q%646.15%
Revenue 1Y (TTM)14.67%
Revenue growth 3Y7.48%
Revenue growth 5Y4.08%
Sales Q2Q%24.84%

3.2 Future

  • Based on estimates for the next years, INVA will show a very strong growth in Earnings Per Share. The EPS will grow by 21.11% on average per year.
  • INVA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.69% yearly.
EPS Next Y-35.99%
EPS Next 2Y-14.03%
EPS Next 3Y-12.55%
EPS Next 5Y21.11%
Revenue Next Year10.03%
Revenue Next 2Y11.33%
Revenue Next 3Y8.64%
Revenue Next 5Y5.69%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
INVA Yearly Revenue VS EstimatesINVA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 100M 200M 300M 400M 500M
INVA Yearly EPS VS EstimatesINVA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

7

4. INVA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 7.68, which indicates a rather cheap valuation of INVA.
  • Based on the Price/Earnings ratio, INVA is valued cheaper than 94.76% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.50, INVA is valued rather cheaply.
  • INVA is valuated reasonably with a Price/Forward Earnings ratio of 11.99.
  • INVA's Price/Forward Earnings ratio is rather cheap when compared to the industry. INVA is cheaper than 84.82% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of INVA to the average of the S&P500 Index (22.62), we can say INVA is valued slightly cheaper.
Industry RankSector Rank
PE 7.68
Fwd PE 11.99
INVA Price Earnings VS Forward Price EarningsINVA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • INVA's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. INVA is cheaper than 94.24% of the companies in the same industry.
  • INVA's Price/Free Cash Flow ratio is rather cheap when compared to the industry. INVA is cheaper than 93.19% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.3
EV/EBITDA 6.94
INVA Per share dataINVA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • INVA has a very decent profitability rating, which may justify a higher PE ratio.
  • INVA's earnings are expected to decrease with -12.55% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.89
EPS Next 2Y-14.03%
EPS Next 3Y-12.55%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. INVA Dividend Analysis

5.1 Amount

  • No dividends for INVA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

INVA Fundamentals: All Metrics, Ratios and Statistics

INNOVIVA INC

NASDAQ:INVA (4/23/2026, 11:08:12 AM)

23.415

-0.09 (-0.36%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-25
Earnings (Next)05-13
Inst Owners107.43%
Inst Owner Change0.34%
Ins Owners0.67%
Ins Owner Change3.42%
Market Cap1.73B
Revenue(TTM)411.33M
Net Income(TTM)271.17M
Analysts81.82
Price Target33.86 (44.61%)
Short Float %8.9%
Short Ratio8.09
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)182.63%
Min EPS beat(2)119.45%
Max EPS beat(2)245.81%
EPS beat(4)3
Avg EPS beat(4)16.52%
Min EPS beat(4)-350.17%
Max EPS beat(4)245.81%
EPS beat(8)4
Avg EPS beat(8)-27.73%
EPS beat(12)7
Avg EPS beat(12)20.38%
EPS beat(16)8
Avg EPS beat(16)-23.72%
Revenue beat(2)2
Avg Revenue beat(2)12.62%
Min Revenue beat(2)9.49%
Max Revenue beat(2)15.75%
Revenue beat(4)4
Avg Revenue beat(4)9.29%
Min Revenue beat(4)5.11%
Max Revenue beat(4)15.75%
Revenue beat(8)8
Avg Revenue beat(8)12.23%
Revenue beat(12)11
Avg Revenue beat(12)11.26%
Revenue beat(16)12
Avg Revenue beat(16)1.54%
PT rev (1m)0.61%
PT rev (3m)2.15%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-6.02%
EPS NY rev (1m)-2.74%
EPS NY rev (3m)-10.67%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.23%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.62%
Valuation
Industry RankSector Rank
PE 7.68
Fwd PE 11.99
P/S 4.22
P/FCF 9.3
P/OCF 8.8
P/B 1.48
P/tB 1.89
EV/EBITDA 6.94
EPS(TTM)3.05
EY13.03%
EPS(NY)1.95
Fwd EY8.34%
FCF(TTM)2.52
FCFY10.75%
OCF(TTM)2.66
OCFY11.36%
SpS5.55
BVpS15.84
TBVpS12.38
PEG (NY)N/A
PEG (5Y)0.89
Graham Number32.9684 (40.8%)
Profitability
Industry RankSector Rank
ROA 16.58%
ROE 23.12%
ROCE 10.33%
ROIC 7.51%
ROICexc 11.69%
ROICexgc 15.62%
OM 39.81%
PM (TTM) 65.92%
GM 74.8%
FCFM 45.32%
ROA(3y)10.94%
ROA(5y)15.78%
ROE(3y)17.71%
ROE(5y)31.01%
ROIC(3y)8.6%
ROIC(5y)13.83%
ROICexc(3y)12.83%
ROICexc(5y)19.03%
ROICexgc(3y)20.63%
ROICexgc(5y)28.4%
ROCE(3y)11.81%
ROCE(5y)19.01%
ROICexgc growth 3Y-23.7%
ROICexgc growth 5Y-16.1%
ROICexc growth 3Y-14.48%
ROICexc growth 5Y-17.86%
OM growth 3Y-13.95%
OM growth 5Y-16.03%
PM growth 3Y0.7%
PM growth 5Y-0.21%
GM growth 3Y-7.93%
GM growth 5YN/A
F-Score5
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 1.38
Debt/EBITDA 1.26
Cap/Depr 26.1%
Cap/Sales 2.55%
Interest Coverage 15.82
Cash Conversion 96.55%
Profit Quality 68.75%
Current Ratio 14.64
Quick Ratio 13.85
Altman-Z 3.57
F-Score5
WACC8.89%
ROIC/WACC0.85
Cap/Depr(3y)12.65%
Cap/Depr(5y)7.7%
Cap/Sales(3y)1.29%
Cap/Sales(5y)0.78%
Profit Quality(3y)311.8%
Profit Quality(5y)233.29%
High Growth Momentum
Growth
EPS 1Y (TTM)1505.26%
EPS 3Y11.17%
EPS 5Y8.59%
EPS Q2Q%646.15%
EPS Next Y-35.99%
EPS Next 2Y-14.03%
EPS Next 3Y-12.55%
EPS Next 5Y21.11%
Revenue 1Y (TTM)14.67%
Revenue growth 3Y7.48%
Revenue growth 5Y4.08%
Sales Q2Q%24.84%
Revenue Next Year10.03%
Revenue Next 2Y11.33%
Revenue Next 3Y8.64%
Revenue Next 5Y5.69%
EBIT growth 1Y-1.87%
EBIT growth 3Y-7.52%
EBIT growth 5Y-12.6%
EBIT Next Year60.04%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1.09%
FCF growth 3Y-2.57%
FCF growth 5Y-9.85%
OCF growth 1Y4.37%
OCF growth 3Y-0.79%
OCF growth 5Y-8.86%

INNOVIVA INC / INVA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for INNOVIVA INC?

ChartMill assigns a fundamental rating of 7 / 10 to INVA.


Can you provide the valuation status for INNOVIVA INC?

ChartMill assigns a valuation rating of 7 / 10 to INNOVIVA INC (INVA). This can be considered as Undervalued.


Can you provide the profitability details for INNOVIVA INC?

INNOVIVA INC (INVA) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for INVA stock?

The Price/Earnings (PE) ratio for INNOVIVA INC (INVA) is 7.68 and the Price/Book (PB) ratio is 1.48.


Can you provide the expected EPS growth for INVA stock?

The Earnings per Share (EPS) of INNOVIVA INC (INVA) is expected to decline by -35.99% in the next year.